Alimera sciences reports second quarter 2024 results

Atlanta, aug. 06, 2024 (globe newswire) -- alimera sciences, inc. (nasdaq: alim) (“alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, today announced financial results for the second quarter of 2024. alimera will not host a conference call today due to the recently announced agreement to be acquired by ani pharmaceuticals, inc. (“ani”).
ALIM Ratings Summary
ALIM Quant Ranking